ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call & Full Presentation скачать в хорошем качестве

ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call & Full Presentation

📊 *ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call* Join ICU Medical's leadership team as they discuss the company's fourth quarter and full-year 2024 financial results, operational highlights, and strategic initiatives. 🔑 *Key Highlights Include:* *Financial Performance:* *Revenue:* Achieved $629.8 million in Q4 2024, surpassing the FactSet estimate of $596.6 million. *Adjusted Earnings Per Share (EPS):* Reported at $2.11, exceeding the FactSet estimate of $1.48. *Full-Year Revenue:* Totaled $2.45 billion for 2024, reflecting a 6% year-over-year increase. *Operational Highlights:* *Product Innovation:* Launched new infusion therapy devices, enhancing patient safety and care efficiency. *Strategic Partnerships:* Formed a joint venture with Otsuka Pharmaceutical Factory to bolster IV solutions manufacturing in North America. *Strategic Outlook:* *2025 Guidance:* Projects revenue growth between 5% and 7%, with adjusted EPS expected to range from $8.50 to $9.00. *Sustainability Initiatives:* Committed to reducing carbon footprint by 15% over the next three years. 📈 Whether you're an investor, healthcare professional, or interested in medical device innovations, this presentation provides valuable insights into ICU Medical's recent performance and future strategies. 📺 *Subscribe* for more earnings calls and presentations from leading companies each quarter!